DOW JONES23,151.84+497.98 2.20%
S&P 5002,713.36+53.95 2.03%
NASDAQ8,032.59+145.33 1.84%

Needham Maintains Buy on NeoGenomics, Raises Price Target to $33

Needham analyst Stephen Unger maintains NeoGenomics (NASDAQ:NEO) with a Buy and raises the price target from $32 to $33.

Benzinga · 03/17/2020 14:43

Needham analyst Stephen Unger maintains NeoGenomics (NASDAQ:NEO) with a Buy and raises the price target from $32 to $33.